Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Oct 09, 2019 11:06am
43 Views
Post# 30211877

RE:gobb, have u seen the operational update

RE:gobb, have u seen the operational updateMoneyman, why dont you provide a life link to the webcast and save everyone some time.

You keep referring to Aug 7 and the Lazard partnership.  Lazard was hired ~a year ago, by the previous management (PL gone Dec 19/18).  Typical it is taking forever to get the mysterious DEAL.

New management has had 10 months to get this DEAL done and yet, crickets.

Ryplazim, I have lost count of how long ago it was they had to insert four checks into the mfg process and provide new batches to FDA.  What have you heard on that front the past TWO YEARS on the new checks, never mind the new batches the take time.  New management has had 10 months to turn things around and nothing.

The detail you mention in the slides is nothing new for this company.  Many promises and no action on the progression of the drugs.

Yes, I know they changed the name, going to NAS and a big deal coming.  All of which does not get us closer to a commercial product, just sets they company up to ask for more money (DILUTION for SH).




moneyman999 wrote:

watch the webcast, pbi4547 nr, nasdaq listing 4th quarter so it is imminent, august 7 did mention a partnership incoming at  final stage negociations (the lazard deal obviously). Riplazim and pbi4050 all detailed as well in slides...all coming... so you are a liar, and like someone said a waste of time.

follow newcamo advice and get a life.
 



<< Previous
Bullboard Posts
Next >>